에이다진 (ADAG)

Adagene Inc ADR 주식(ADAG)의 최신 뉴스

Short Interest in Adagene Inc. (NASDAQ:ADAG) Expands By 6.3% - MarketBeat

MarketBeat

Short Interest in Adagene Inc. (NASDAQ:ADAG) Rises By 6.3% - Defense World

Defense World

WuXi AppTec Co. Ltd. Takes Position in Adagene Inc. (NASDAQ:ADAG) - MarketBeat

MarketBeat

WuXi AppTec Co. Ltd. Takes Position in Adagene Inc. (NASDAQ:ADAG) - MarketBeat

MarketBeat

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewswire

GlobeNewswire

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

GlobeNewswire Inc.

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board - GlobeNewswire

GlobeNewswire

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 - GlobeNewswire

GlobeNewswire

Adagene expands partnership with Merck for colorectal cancer - Clinical Trials Arena

Clinical Trials Arena

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

GlobeNewswire Inc.

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody ... - GlobeNewswire

GlobeNewswire

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 - ANTARA English

ANTARA English

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Benzinga

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

GlobeNewswire Inc.

Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium

GlobeNewswire Inc.

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody ... - Yahoo Finance

Yahoo Finance

Adagene to Present at Investor and Scientific Conferences in September - GlobeNewswire

GlobeNewswire

Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody ... - Yahoo Finance

Yahoo Finance

Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo News UK

Yahoo News UK

HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace

InvestorPlace

Sanofi picks a 'safe' bet for Adagene's antibody tech in $2.5B biobucks tie up - Fierce Biotech

Fierce Biotech

Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories - PR Newswire

PR Newswire